Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 2

Conditions

Breast Neoplasms 60Neoplasms 58Lung Neoplasms 32Prostatic Neoplasms 24Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 21Neoplastic Cells, Circulating 20Head and Neck Neoplasms 19Pancreatic Neoplasms 17Melanoma 14Ovarian Neoplasms 13Carcinoma, Hepatocellular 12Esophageal Neoplasms 10Colonic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Glioma 9Squamous Cell Carcinoma of Head and Neck 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Sarcoma 7Neoplasm Metastasis 7Endometrial Neoplasms 7Stomach Neoplasms 6Neoplasm, Residual 6Myeloproliferative Disorders 6Leukemia 6Kidney Neoplasms 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6

Interventions

Heparin, Low-Molecular-Weight 2Blood Specimen Collection 2apixaban 1Ultrasonography 1Standard of Care 1Rivaroxaban 1Data Collection 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Thrombosis × Blood Specimen Collection × Clear all
NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Wake Forest University Health Sciences

Recruiting
35 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

NCT05839717 2024-12-17

CLOJAK

University Hospital, Bordeaux

Recruiting
120 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡